Literature DB >> 2630532

Megakaryocytes in the yolk sac, liver and bone marrow of the mouse: a cytometrical analysis by semithin light microscopy.

G Matsumura1, K Sasaki.   

Abstract

Megakaryocytes of the yolk sac, liver and bone marrow were cytometrically observed by light microscopy using semithin plastic sections. In the yolk sac at 10 and 11 days of gestation, megakaryocytes contained an irregularly round nucleus and clearly stained short lines corresponding to the demarcation membranes. All yolk sac megakaryocytes were less than 10 microns in diameter. Large megakaryocytes appeared in the fetal liver at 12 days and increased in number thereafter. Megakaryocytes in the fetal liver changed in their size between 12 and 15 days of gestation. Liver megakaryocytes at 15 days of gestation and during the neonatal period showed similar distribution profiles in cell size and nuclear-cytoplasmic ratio as adult bone marrow megakaryocytes.

Entities:  

Mesh:

Year:  1989        PMID: 2630532      PMCID: PMC1256831     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  4 in total

1.  [Classifications of megakaryopoietic cells on plastic semithin sections: effects of pregnancy and estrogen administration on megakaryopoiesis].

Authors:  G Matsumura; K Sasaki
Journal:  Kaibogaku Zasshi       Date:  1986-10

2.  The ultrastructure of megakaryopoietic cells of the yolk sac and liver in mouse embryo.

Authors:  G Matsumura; K Sasaki
Journal:  Anat Rec       Date:  1988-10

3.  Fetal hemopoiesis. I. Electron microscopic studies on human yolk sac hemopoiesis.

Authors:  T Fukuda
Journal:  Virchows Arch B Cell Pathol       Date:  1973-12-07

4.  The significance of megakaryocyte size.

Authors:  R F Levine; K C Hazzard; J D Lamberg
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

  4 in total
  3 in total

1.  The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis.

Authors:  Joanna Tober; Anne Koniski; Kathleen E McGrath; Radhika Vemishetti; Rachael Emerson; Karen K L de Mesy-Bentley; Richard Waugh; James Palis
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

2.  Maternal erythrocyte ENT1-mediated AMPK activation counteracts placental hypoxia and supports fetal growth.

Authors:  Seisuke Sayama; Anren Song; Benjamin C Brown; Jacob Couturier; Xiaoli Cai; Ping Xu; Changhan Chen; Yangxi Zheng; Takayuki Iriyama; Baha Sibai; Monica Longo; Rodney E Kellems; Angelo D'Alessandro; Yang Xia
Journal:  JCI Insight       Date:  2020-05-21

3.  The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.

Authors:  Roxanna A Irani; Yujin Zhang; Sean C Blackwell; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.